Australian pharmaceutical policy and the idea of innovation

Evan Doran, David Henry, Thomas A. Faunce, Andrew Searles

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

In Australia, regulation of the pharmaceutical sector is falling in thrall of the idea of innovation - an idea holding the promise of both technological advance and economic growth. Australian pharmaceutical policy, historically concerned with securing public access to quality drugs while containing costs, is gradually but perceptibly shifting emphasis towards promoting private sector profitability and expansion. Innovation, conceived and presented as a rational and necessary predicate for improving the nation’s health and international competitiveness, is central to this change in policy direction. This paper interprets changes to Australian pharmaceutical policy from the view that ideas as well as interests shape public policy. We argue that a sequence of material changes in regulation shows the rise in prominence of the idea of innovation – an idea resonant with contemporary economic wisdom and general public sympathy towards new technologies.
Original languageEnglish
Pages (from-to)39-61
Number of pages23
JournalJournal of Australian Political Economy
Volume62
Publication statusPublished - Dec 2008
Externally publishedYes

Fingerprint

pharmaceutical
innovation
regulation
open channel
sympathy
profitability
wisdom
competitiveness
new technology
private sector
economic growth
public policy
drug
costs
health
economics
Innovation
Pharmaceuticals
Technological advances
Economics

Cite this

Doran, Evan ; Henry, David ; Faunce, Thomas A. ; Searles, Andrew. / Australian pharmaceutical policy and the idea of innovation. In: Journal of Australian Political Economy. 2008 ; Vol. 62. pp. 39-61.
@article{aef22e58fd374b50a2467f1af4510544,
title = "Australian pharmaceutical policy and the idea of innovation",
abstract = "In Australia, regulation of the pharmaceutical sector is falling in thrall of the idea of innovation - an idea holding the promise of both technological advance and economic growth. Australian pharmaceutical policy, historically concerned with securing public access to quality drugs while containing costs, is gradually but perceptibly shifting emphasis towards promoting private sector profitability and expansion. Innovation, conceived and presented as a rational and necessary predicate for improving the nation’s health and international competitiveness, is central to this change in policy direction. This paper interprets changes to Australian pharmaceutical policy from the view that ideas as well as interests shape public policy. We argue that a sequence of material changes in regulation shows the rise in prominence of the idea of innovation – an idea resonant with contemporary economic wisdom and general public sympathy towards new technologies.",
author = "Evan Doran and David Henry and Faunce, {Thomas A.} and Andrew Searles",
year = "2008",
month = "12",
language = "English",
volume = "62",
pages = "39--61",
journal = "Journal of Australian Political Economy",
issn = "0156-5826",
publisher = "University of Sydney",

}

Australian pharmaceutical policy and the idea of innovation. / Doran, Evan; Henry, David; Faunce, Thomas A.; Searles, Andrew.

In: Journal of Australian Political Economy, Vol. 62, 12.2008, p. 39-61.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Australian pharmaceutical policy and the idea of innovation

AU - Doran, Evan

AU - Henry, David

AU - Faunce, Thomas A.

AU - Searles, Andrew

PY - 2008/12

Y1 - 2008/12

N2 - In Australia, regulation of the pharmaceutical sector is falling in thrall of the idea of innovation - an idea holding the promise of both technological advance and economic growth. Australian pharmaceutical policy, historically concerned with securing public access to quality drugs while containing costs, is gradually but perceptibly shifting emphasis towards promoting private sector profitability and expansion. Innovation, conceived and presented as a rational and necessary predicate for improving the nation’s health and international competitiveness, is central to this change in policy direction. This paper interprets changes to Australian pharmaceutical policy from the view that ideas as well as interests shape public policy. We argue that a sequence of material changes in regulation shows the rise in prominence of the idea of innovation – an idea resonant with contemporary economic wisdom and general public sympathy towards new technologies.

AB - In Australia, regulation of the pharmaceutical sector is falling in thrall of the idea of innovation - an idea holding the promise of both technological advance and economic growth. Australian pharmaceutical policy, historically concerned with securing public access to quality drugs while containing costs, is gradually but perceptibly shifting emphasis towards promoting private sector profitability and expansion. Innovation, conceived and presented as a rational and necessary predicate for improving the nation’s health and international competitiveness, is central to this change in policy direction. This paper interprets changes to Australian pharmaceutical policy from the view that ideas as well as interests shape public policy. We argue that a sequence of material changes in regulation shows the rise in prominence of the idea of innovation – an idea resonant with contemporary economic wisdom and general public sympathy towards new technologies.

UR - http://www.scopus.com/inward/record.url?scp=70349606238&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 39

EP - 61

JO - Journal of Australian Political Economy

JF - Journal of Australian Political Economy

SN - 0156-5826

ER -